Rating History for Pharmacyclics (PCYC) by Piper Sandler

More Stocks Rated by Piper Sandler | Latest Ratings for PCYC
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
5/2/2014 N/A Downgrade Neutral
(Overweight)		 N/A
(N/A)		 95.21
(261.25)		 174.39% Details